Advancing cardiovascular outcomes with dapagliflozin and sacubitril in post-acute myocardial infarction heart failure and type 2 diabetes mellitus.
在急性心肌梗塞後心衰竭及第二型糖尿病中,使用 dapagliflozin 和 sacubitril 改善心血管結果。
World J Clin Cases 2024-12-27
Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trial.
急性心肌梗塞患者中使用 Empagliflozin 的效果:針對有無第二型糖尿病的預先指定分析,來自 EMPACT-MI 試驗。
Eur J Heart Fail 2024-12-26
Assessing the benefit-risk profile of newer glucose-lowering drugs: A systematic review and network meta-analysis of randomized outcome trials.
評估新型降糖藥物的利益風險概況:隨機結果試驗的系統性回顧與網絡Meta分析。
Diabetes Obes Metab 2024-12-26
Comparing the Efficacy and Long-Term Outcomes of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Metformin, and Insulin in the Management of Type 2 Diabetes Mellitus.
比較鈉-葡萄糖共轉運蛋白-2 (SGLT2) 抑制劑、二肽基肽酶-4 (DPP-4) 抑制劑、Metformin 和胰島素在 2 型糖尿病管理中的療效及長期結果。
Cureus 2024-12-26
Which antidiabetic drugs do patients of T2DM prefer in India and why? A discrete choice experiment.
印度2型糖尿病患者偏好的抗糖尿病藥物及其原因:一項離散選擇實驗。
J Family Med Prim Care 2024-12-26
A study of SGLT2 inhibitors on levels of plasma atherogenesis biomarkers in diabetes.
SGLT2 抑制劑對糖尿病患者血漿動脈粥樣硬化生物標記物水平的研究。
J Family Med Prim Care 2024-12-26
Leveraging Green Chromatography in Quality-by-Design-Driven Study for the Simultaneous Analysis of Essential Single-Pill Antidiabetic Drug Combinations.
利用綠色色譜技術於品質設計驅動研究中,同時分析基本單顆抗糖尿病藥物組合。
J Sep Sci 2024-12-25
The association between sodium-glucose cotransporter 2 inhibitors and contrast-associated acute kidney injury in patients with type 2 diabetes undergoing angiography: a propensity-matched study.
鈉-葡萄糖共轉運蛋白 2 抑制劑與接受血管造影的 2 型糖尿病患者對比劑相關急性腎損傷之間的關聯:一項傾向配對研究。
Eur J Med Res 2024-12-24